GE HEALTHCARE TECHNOLOGIES INC. (GEHC) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $17.59B (period ending 2021-12-31) to $20.63B (period ending 2025-12-31) — a 4.1% annual pace across 4 year(s) of filed history.
- Net margin compressed from 12.8% to 10.1% over that same span.
- Across 13 tracked quarters, the strongest was $5.14B (quarter ending 2025-09-30) and the weakest was $4.34B (quarter ending 2022-03-31).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $20.63B | 2025-12-31 | 10-K | 0001932393-26-000007 |
| Gross profit | $8.25B | 2025-12-31 | 10-K | 0001932393-26-000007 |
| Operating income | $2.76B | 2025-12-31 | 10-K | 0001932393-26-000007 |
| Net income | $2.08B | 2025-12-31 | 10-K | 0001932393-26-000007 |
| Diluted EPS | $4.55 | 2025-12-31 | 10-K | 0001932393-26-000007 |
| Total assets | $36.91B | 2025-12-31 | 10-K | 0001932393-26-000007 |
| Total liabilities | $26.31B | 2025-12-31 | 10-K | 0001932393-26-000007 |
| Cash & equivalents | $4.49B | 2025-12-31 | 10-K | 0001932393-26-000007 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $5.13B | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Gross profit | $1.98B | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Operating income | $515.0M | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Net income | $389.0M | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Diluted EPS | $0.85 | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Total assets | $37.13B | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Total liabilities | $26.23B | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Cash & equivalents | $2.26B | 2026-03-31 | 10-Q | 0001932393-26-000031 |
| Operating cash flow | $290.0M | 2026-03-31 | 10-Q | 0001932393-26-000031 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
GE Healthcare Technologies Inc. (GEHC) operates with substantial scale, as evidenced by its $20.63 billion annual revenue in 2025 and $36.91 billion total assets. The company’s mix is heavily weighted towards health technology solutions, reflected in its consistent growth trajectory over the past four years, with revenue expanding at a 4.1% annual pace. However, this expansion has coincided with a compression of net margin from 12.8% to 10.1%, indicating potential pressure on profitability.
The multi-year trend reveals a steady increase in revenue, albeit at a moderate rate, suggesting a focus on market penetration rather than rapid expansion. The net income has shown fluctuations, with a notable dip in 2023 before recovering slightly in 2024 and 2025. Quarterly performance indicates seasonality, with the strongest quarter being Q3 2025 at $5.14 billion and the weakest Q1 2022 at $4.34 billion.
In the upcoming filings, investors should monitor the company’s ability to maintain revenue growth while addressing the margin compression. Additionally, the consistency of quarterly performance and the management’s strategies to navigate potential market volatility will be crucial factors to observe.
Source: SEC EDGAR company facts for CIK 0001932393 · filings index